TriLogic Pharma

What TriLogic Pharma does

TriLogic Pharma LLC is a privately held veterinary pharmaceutical company headquartered in Montgomery, United States, focused on the development and commercialization of advanced drug delivery systems for companion animal health. The company was founded around 2000 by James A. H. Harwick (Co-Founder, President, and CEO) and Hemant H. Alur (Co-Founder, Vice President and Chief Scientific Officer), with cumulative disclosed equity funding of approximately $2.97M raised across four rounds between 2007 and 2012.

The company's core technology is the BioGel XR platform, an in-situ gelation hydrogel system that combines a tri block copolymer with a natural polysaccharide. The platform exploits reverse thermal gelation triggered by body temperature, transforming a low-viscosity liquid into a gel at the site of application and providing sustained erosion over a 15-day window with bioresorbable, biocompatible material properties. The lead commercial product built on this platform is Clindoral, a clindamycin-based periodontal filler for dogs and cats designed to treat stages 1-3 periodontal disease, offering single-step prefilled syringe placement and 7-10 day in-pocket residence. A PCT patent application has been filed covering the underlying formulation.

TriLogic operates a channel-based go-to-market model, distributing its products through a US network of established veterinary supply partners including Covetrus, MWI Veterinary Supply, Midwest Veterinary Supply, Penn Veterinary Supply, Patterson Veterinary Supply, and Victor Medical Company, which collectively reach the bulk of US companion animal veterinary practices. Revenue is generated through direct product sales into the veterinary channel at undisclosed pricing, targeting vertical specialists in companion animal dentistry. The headcount is reported at 1-10 employees, consistent with a small specialty pharma operating model.

Name

TriLogic Pharma

Legal name

TriLogic Pharma LLC

Website

https://trilogicpharma.com

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

1–10 employees

Short description

TriLogic Pharma LLC is a private US veterinary pharmaceutical company that develops and sells hydrogel-based drug delivery products, including the Clindoral periodontal filler, for companion animal dental practices via major veterinary distributors.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Companion Animal Therapeutics (Rx) (HLAMAEAA)

Keywords

• Veterinary pharmaceuticals
• Hydrogel drug delivery
• Animal health products
• Periodontal treatment
• In-situ gel technology

Headquarters

HQ city

Montgomery

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Marketing or Sales, Personnel

Revenue model

1. Veterinary Pharmaceutical Product Sales: TriLogic Pharma generates revenue through the sale of proprietary veterinary pharmaceutical products, including BioGel XR (hydrogel platform technology) and Clindoral (periodontal filler for companion animals). Products are distributed through veterinary supply channel partners.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

TriLogic Pharma develops and markets proprietary hydrogel drug delivery solutions for animal health. The company commercializes BioGel XR, an in-situ gelation platform technology combining tri block copolymer with natural polysaccharide, and Clindoral, a clindamycin-based periodontal filler gel for dogs and cats. Products are sold to veterinary practices through a national network of veterinary supply distributors.

Product overview

TriLogic Pharma operates as a veterinary pharmaceutical company focused on advanced drug delivery solutions for animal health. The company offers two primary products: BioGel XR, a proprietary in-situ gelling hydrogel technology platform that uses body temperature-triggered sol-to-gel transition for sustained drug delivery; and Clindoral, a clindamycin-based periodontal filler for treating periodontal disease in dogs and cats. The BioGel XR platform serves as the underlying technology foundation, while Clindoral represents an application of this technology for oral/dental care.

Differentiator

Problem solved

Functional benefit

Brands

• BioGel XR: Proprietary in-situ gel platform technology combining tri block copolymer and natural polysaccharide for veterinary applications.
• Clindoral

Products and services

• BioGel XR

Quantifiable outcome

• BioGel XR matrix erodes over 15 days under controlled condition, representing a 5-fold increase over tri block copolymer alone
• +3 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Six partnerships are on record, tiered core.

• CovetruscoreChannel Partner/ Reseller/ DistributorCovetrus is a major veterinary supply distributor that distributes TriLogic Pharma products to veterinary practices across the United States.
• MWI Veterinary SupplycoreChannel Partner/ Reseller/ DistributorMWI Veterinary Supply is a national veterinary supply distributor serving animal hospitals and clinics with TriLogic Pharma products.
• Midwest Veterinary SupplycoreChannel Partner/ Reseller/ DistributorMidwest Veterinary Supply distributes TriLogic Pharma veterinary products to veterinary practices.
• Penn Veterinary SupplycoreChannel Partner/ Reseller/ DistributorPenn Veterinary Supply serves as a distribution partner for TriLogic Pharma veterinary products.
• Patterson Veterinary SupplycoreChannel Partner/ Reseller/ DistributorPatterson Veterinary Supply is a major veterinary supply distributor that stocks and distributes TriLogic Pharma products.
• Victor Medical CompanycoreChannel Partner/ Reseller/ DistributorVictor Medical Company distributes TriLogic Pharma veterinary products to veterinary practices.

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Vetoquinol: Independent veterinary pharmaceutical company with strong companion animal dental and periodontal presence (e.g., Easofen, dental chews), competing for the same vet practice shelf space as TriLogic.
• Ceva Santé Animale: Global veterinary pharmaceutical company with a broad companion animal portfolio; comparable as a multi-species animal health innovator and direct channel competitor.
• Dechra Pharmaceuticals: Specialty veterinary pharma focused on companion animal therapeutics; comparable as a small/mid-tier pharmaceutical manufacturer selling through US vet distribution channels.
• Phibro Animal Health: Diversified animal health and nutrition company; relevant comparable as an established veterinary pharma manufacturer selling through US distribution channels.
• Virbac: Global veterinary pharmaceutical company with a dedicated companion animal dental product line (CET enzymatic dental hygiene), competing directly in the same vet dental channel TriLogic serves.
• Zoetis: Largest global animal health company; sells Doxirobe, the incumbent clindamycin/doxycycline periodontal filler TriLogic's Clindoral is clinically benchmarked against — making Zoetis the most direct competitive incumbent.
• Elanco Animal Health: Major animal health company with broad companion animal therapeutic portfolio; relevant competitor/partner for specialty veterinary pharma positioning and channel relationships.

Emerging players

• Aratana Therapeutics: Specialty companion animal therapeutics developer (now part of Elanco); relevant comparability as an early-stage commercial veterinary therapeutics company selling through US vet distribution.

Others

• Patterson Companies: One of the largest US veterinary distributors (Patterson Veterinary Supply) that distributes TriLogic's products; relevant because channel economics and listing decisions at Patterson materially affect TriLogic's commercial reach.
• Covetrus: Major US veterinary distribution platform (formerly part of VCA/Antech) and the lead distributor of TriLogic's products; included because Covetrus listing/relationship dynamics are central to TriLogic's commercial success.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/trilogic-pharma-llc

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds4 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TriLogic Pharma